Following 2 days of testimonials and discussions with regards to silicone breast implants, one of the top government health officials has said that they have not heard anything that can shake their faith in the safety of these implants.
Dr. William Maisel who is the chief scientist from the Food and Drug Administration’s Center for Devices stated that silicone breast implants had no danger.
“We felt that way before the meeting, and we continue to feel the same after the presentations and discussions over the last two days,” Dr. Maisel said.
However, Dr Maisel does not dispute the fact that there are a few risks pertaining these implants such as ruptures, infection, hardening of the area around the implants, scarring, the need to remove the implants as well as asymmetry. Nonetheless, women have no reason not to be at rest since F.D.A believes that the silicone breast implants on the market today are safe, Dr. Maisel commented.
But despite all the above comforting statements, some of the patients and women groups testified otherwise. For example, the president of the National Research Center for Women and Families, Diana Zuckerman testified before the panel saying that Allergan and Johnson & Johnson, 2 of the companies that manufacture these implants did a poor job when studying the people that they gave these implants.
“And without the right data, we still do not know how safe or effective they are and whether there are certain patients at risk for extremely negative outcomes,” Ms. Zuckerman said.
To this claim, Dr. Maisel agreed that the studies done by the above mentioned companies did fail to follow as many patients as the agency had envisioned.
The aim of this meeting was to inquire from the expert panel what the 2 companies plus the agency should do regarding the poor follow up. Some said that patients ought to be compensated for their participation; some others said that doctors ought to receive some money as well.
There was criticism regarding the 27 paged research form given to patients who are participating in this study to fill out. Many were wondering if it could be made shorter. Most people there hoped that a registry would be made in a bid to follow up on the breast implant patients however those registries are costly as far as maintenance is concerned and not easy to create.
The panel came to a conclusion that patients should not agree to being told to get a magnetic resonance imaging test 3 years after the implant procedure as well as 2 years after. The reason behind this test is to check for rupturing as these implants usually rapture without the women being aware. But with the test being so costly, uncertainty of what to do when a rapture is located, and the fact that the dangers of ruptured implants may not be more than those of the operation to get them out , many women have ignored it all.
“F.D.A. believes and so does the panel that Magnetic Resonance Imaging is the gold standard for evaluating breast implants for silent ruptures,” Dr. Maisel said. “But there was consensus among the panel that the requirements for ongoing Magnetic Resonance Imaging must be removed.”
Dr. Maisel promised that the F.D.A. would study whether to follow this advice or not.